Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
8.95M
-
Shares change
-
-68.1K
-
Total reported value, excl. options
-
$103M
-
Value change
-
-$552K
-
Number of buys
-
18
-
Number of sells
-
-15
-
Price
-
$11.51
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2020
48 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q4 2020.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.95M shares
of 92.4M outstanding shares and own 9.69% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.41M shares), ORBIMED ADVISORS LLC (1.48M shares), BlackRock Inc. (719K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (666K shares), VANGUARD GROUP INC (596K shares), MILLENNIUM MANAGEMENT LLC (335K shares), Fosun International Ltd (324K shares), STATE STREET CORP (223K shares), GEODE CAPITAL MANAGEMENT, LLC (185K shares), and NORTHERN TRUST CORP (178K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.